.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) recently reached a significant milestone. By deploying next-generation Spectral CT imaging, this Tata Memorial Centre unit aims to revolutionize early cancer detection in India. This advanced technology addresses the growing cancer burden by providing clinicians with unprecedented diagnostic precision. Consequently, patients may experience fewer diagnostic delays and more targeted treatment plans.
The newly commissioned Spectral CT 7500 captures detailed spectral data during routine scans. This capability allows for deeper disease characterization without increasing the patient's radiation dose. Furthermore, the platform performs comprehensive full-body scans in just two seconds. Therefore, clinicians can make faster decisions in high-volume oncology settings. Clinical studies suggest that this detector-based technology leads to 36 percent fewer follow-up diagnostic procedures. Specifically, it minimizes the need for repeat imaging, which reduces patient anxiety and care timelines.
Beyond its primary role in oncology, the technology offers significant advantages for other medical fields. Notably, it supports cardiology, neurology, and emergency care services. In these areas, rapid clinical assessment often determines patient outcomes. Therefore, the integration of spectral imaging enhances workflow efficiency across multiple hospital departments. This multi-system approach is vital for addressing the rising incidence of complex diseases in India.
Q1: How does Spectral CT imaging improve diagnostic accuracy?
It provides detailed tissue characterization and monochromatic images. This helps clinicians differentiate between similar-looking structures, leading to more precise diagnoses.
Q2: Does Spectral CT imaging increase radiation exposure?
No, the technology captures spectral information during routine scans without adding radiation dose. It actually reduces overall exposure by eliminating the need for many follow-up exams.
Q3: Which departments benefit from this technology?
While primarily used in oncology, it is also highly effective in cardiology, neurology, and emergency medicine for rapid and confident clinical assessments.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
ACTREC and TMC introduce Spectral CT 7500 to improve diagnostic precision, reduce radiation, and streamline cancer detection pathways in India....
6 months ago
A new case study illuminates how functional connectivity changes drive recovery from pure alexia following posterior cerebral artery infarction. Functional reorganization supports reading recovery despite permanent structural tract disconnection, highlighting key implications for stroke rehabilitation.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
